A Phase II Study Evaluating the Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis

Clinical trial NCT02267642 · COMPLETED

Trial details

NCT number: NCT02267642
Sponsor: AbGenomics B.V Taiwan Branch
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Psoriatic Arthritis

Start date: 2015-01-01
Primary completion: 2015-10-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.